Mark R. Tanner
The University of Texas MD Anderson Cancer Center(US)The University of Texas MD Anderson Cancer Center(US)
Publications by Year
Research Areas
Multiple Myeloma Research and Treatments, Ion channel regulation and function, Protein Degradation and Inhibitors, Hematopoietic Stem Cell Transplantation, Acute Myeloid Leukemia Research
Most-Cited Works
- → AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9(2020)219 cited
- → Kv1.3 channel‐blocking immunomodulatory peptides from parasitic worms: implications for autoimmune diseases(2014)91 cited
- → A potent and Kv1.3-selective analogue of the scorpion toxin HsTX1 as a potential therapeutic for autoimmune diseases(2014)81 cited
- → Prolonged immunomodulation in inflammatory arthritis using the selective Kv1.3 channel blocker HsTX1[R14A] and its PEGylated analog(2017)74 cited
- → Clonal Hematopoiesis Is Associated with Increased Risk of Severe Neurotoxicity in Axicabtagene Ciloleucel Therapy of Large B-Cell Lymphoma(2022)70 cited
- → Blocking KV1.3 Channels Inhibits Th2 Lymphocyte Function and Treats a Rat Model of Asthma(2014)68 cited